AACR 2024: Drug Targets, part-1
Margaret Foti, PhD, MD, chief executive officer of the American Association for Cancer Research (AACR), kicked off this year’s opening ceremony celebrating an outstanding year for the organization.
Randomized Controlled Trials (RCTs) and Real-world Outcomes in Hematological Malignancies: Minding the Gap
NeoGenomics Honored with Platinum Design Award for the NeoAccess Technology Platform
NeoAccess™, the new clinical decision-support platform for oncologists was built on user experience (UX) and design thinking prin
SITC Overview 2023
Following from last year’s record year of attendance held in Boston, this year’s 38th annual Society for Immunotherapy of Cancer (SITC) meeting held in sunny San Diego proved just as popular attrac
NeoGenomics highlighting advances in drug development strategies at recent clinical meetings
NeoGenomics is pleased to have attended meetings this year where we've had the opportunity to highlight advances in drug development strategies.
Women's Health and Fitness Day
September 27 is National Women's Health And Fitness Day. This annual observance strives to spread education about health and wellness, encourage women to prioritize their health, and more.
Advancements in the Treatment of Glioblastoma Using Oncolytic Viruses
While current oncology research is revealing both diagnostic and prognostic markers as well as predictive cell states, and identities with implications for drug and diagnostic development, it is ch